Cargando…
Veverimer for treatment of chronic metabolic acidosis in patients with chronic kidney disease
Autores principales: | Gone, Anirudh R., Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729350/ https://www.ncbi.nlm.nih.gov/pubmed/33313284 http://dx.doi.org/10.21037/atm-20-3320 |
Ejemplares similares
-
Veverimer: an advance in base therapy for metabolic acidosis
por: Brady, Clayton, et al.
Publicado: (2020) -
Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis
por: Liu, Wenlin, et al.
Publicado: (2021) -
Effects of Veverimer in Older Adults With CKD and Metabolic Acidosis
por: Tangri, Navdeep, et al.
Publicado: (2021) -
New solutions to old problems—metabolic acidosis in chronic kidney disease
por: Sy, John, et al.
Publicado: (2020) -
Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial
por: Mathur, Vandana S, et al.
Publicado: (2021)